Table 2.
Primary and secondary outcomes in patients in inhalation phage therapy and placebo groups.
| Outcome | Inhalation phage therapy N = 30 |
Placebo N = 30 |
P-value |
|---|---|---|---|
| No cough or improvement | 28 | 25 | 0.6 |
| No fever | 28 | 22 | 0.04 |
| No dyspnea | 21 | 12 | 0.008 |
| No fatigue or improvment | 20 | 22 | 0.38 |
| Negative sputum culture | 26 | 15 | 0.02 |
| Survival rate | 29 | 28 | 0.5 |
| No severe secondary infection | 28 | 21 | 0.03 |
| Duration of hospitalization | 5.1 ± 1.01 | 9.53 ± 2.07 | 0.04 |
| Duration of incubation or under ventilation | 3 ± 0.05 | 6 ± 2.01 | 0.02 |
| Duration of stay in ICU | 9.1 ± 1.01 | 9.53 ± 0.679 | 0.9 |